Lifecore Biomedical, Inc. LFCR 深 滬
等待開盤 03-26 09:30:00 美东时间
4.19
+0.190
+4.75%
華盛通- 最 高4.36
- 今 開4.02
- 成交量 40.34万股
- 最 低 4.02
- 昨 收 4.00
- 總市值 1.57亿
- 52周最高 8.9799
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 3.87
- 委 比 -6.21%
- 總股本 3747.74万
- 歷史最高 15.96
- 量 比 0.65
- 振 幅 8.50%
- 歷史最低 1.52
- 每 手 1
- 風險率 0.83%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Lifecore Expands Manufacturing Deal With Existing Pharma Client
Lifecore Biomedical, Inc. (NASDAQ:LFCR) ("Lifecore"), a fully integrated injectables contract development and manufacturing organization ("CDMO"), today announced that it has signed two CDMO manufacturing service
今天 19:12
BUZZ-U.S. STOCKS ON THE MOVE-United Airlines, Synopsys, PG&E
BUZZ-U.S. STOCKS ON THE MOVE-United Airlines, Synopsys, PG&E Workspace search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 March 20 (Reuters) - Wall Street futures jumped more than 2% on Monda
03-23 20:22
BUZZ-Lifecore rises as new manufacturing deal supports growth outlook
BUZZ-Lifecore rises as new manufacturing deal supports growth outlook ** Shares of drug contract manufacturer Lifecore Biomedical LFCR.O rise 1.4% to $4.07 premarket ** Co says it signed a manufacturing agreement with a new customer in the aesthetics market ** Deal involves taking over U.S. producti
03-23 19:24
Catalyst Watch: Eyes on post-Iran economic data, Fedspeak, and cybersecurity
Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Read more about the events that may impact stock prices next week. Monday - March 23 ...
03-21 03:00
美股大行评级 | 摩根大通上调哔哩哔哩至"超配"，目标价从27美元升至35美元；Rhythm遭花旗、大摩等多家机构下调目标价
今日重点评级关注：韦德布什：维持Black Diamond Therapeutic"跑赢大市"评级，目标价从13美元升至14美元；花旗：维持Olema Pharmaceuticals"买入"评级，目标价从60美元升至62美元
03-18 10:48
Lifecore Biomedical shares are trading lower after the company reported mixed Q2 financial results and issued FY26 sales guidance below estimates.
Lifecore Biomedical shares are trading lower after the company reported mixed Q...
03-16 23:01
BRIEF-Lifecore Biomedical Reports Financial Results For The Fourth Quarter And Transition Period Ended December 31, 2025, And Provides Corporate Update
BRIEF-Lifecore Biomedical Reports Financial Results For The Fourth Quarter And Transition Period Ended December 31, 2025, And Provides Corporate Update March 16 (Reuters) - Lifecore Biomedical Inc LFCR.O : LIFECORE BIOMEDICAL REPORTS FINANCIAL RESULTS FOR THE FOURTH QUARTER AND TRANSITION PERIOD END
03-16 20:17
Lifecore Biomedical Sees FY2026 Sales $120.000M-$125.000M vs $129.846M Est
Lifecore Biomedical (NASDAQ:LFCR) sees FY2026 sales of $120.000 million-$125.000 million vs $129.846 million analyst estimate.
03-16 20:05
Lifecore Biomedical Q2 EPS $(0.16) Misses $(0.15) Estimate, Sales $35.747M Beat $35.224M Estimate
Lifecore Biomedical (NASDAQ:LFCR) reported quarterly losses of $(0.16) per share which missed the analyst consensus estimate of $(0.15) by 6.67 percent. This is a 36 percent increase over losses of $(0.25) per share from
03-16 20:02
Earnings Scheduled For March 16, 2026
Companies Reporting Before The Bell • CytomX Therapeutics (NASDAQ:CTMX) is expe...
03-16 19:11
